Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Court Orders Balance of Nature to Halt Supplement Sales
“The public cannot have confidence that their products are what they purport to be,” says the FDA.
Court orders Balance of Nature to stop sales of supplements after FDA lawsuits
Alexander Tin, CBS News
CATrends: Deceptive Pricing Tactics
What consumers need to watch out for this holiday shopping season.
Pixelup
Users report that this app’s photo-enhancing claims are far from picture-perfect.
Cox Mobile
Spoiler: In order to be eligible for Cox Mobile, customers must already have Cox Internet.